MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/17562848261462398

Медицинская библиотека · Therapeutic advances in gastroenterology · 2026

Using artificial intelligence to identify characteristics associated with clinical and economic outcomes in MASH (FOCUS-MASH).

Mangla Kamal Kant, Gbadamosi Semiu O, Semeniuta Daniel, Bandaria Jigar, Zabinski Joseph, Curhan Gary, Boussios Costas

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Heterogeneity in the disease characteristics of metabolic dysfunction-associated steatohepatitis (MASH) complicates efforts to identify individuals with high unmet need.

OBJECTIVE

We used artificial intelligence (AI) phenotyping to identify factors associated with rapid fibrosis progression, long-term clinical outcomes, and high healthcare costs.

DESIGN

In this retrospective cohort study (January 1, 2013-September 1, 2022), patients with a MASH diagnosis, a Fibrosis-4 index score within 90 days of first MASH diagnosis, and no other liver diseases were identified in a United States electronic medical records and claims dataset.

METHODS

Using machine learning, characteristics, including diagnoses, procedures, and medications, were grouped into phenotypic signals, which were iteratively refined and evaluated for strength of association with each outcome. Differences between subgroups in the proportions of patients with specific phenotypic signals were calculated.

RESULTS

In total, 14,707 patients were included in at least one analysis. Rapid fibrosis progression (n = 1795) was associated with a history of anemia, thrombocytopenia, and cardiovascular (CV) diagnoses. Long-term liver- and CV-related outcomes (n = 13,880) were associated with chronic diseases, kidney diagnoses, cardiac diagnoses, medications, lab tests, and injuries. High healthcare costs (n = 10,133) were associated with heart failure procedure codes, cardiac diagnoses and testing, hospitalization procedure codes and kidney diagnoses, and gastrointestinal diagnoses and abdominal imaging.

CONCLUSION

This study demonstrates the application of AI phenotyping to multidimensional real-world data. This approach could support new methods for proactively identifying patients in clinical practice who require closer monitoring and management.

Для цитирования: Mangla Kamal Kant, Gbadamosi Semiu O, Semeniuta Daniel, Bandaria Jigar, Zabinski Joseph, Curhan Gary, Boussios Costas. Using artificial intelligence to identify characteristics associated with clinical and economic outcomes in MASH (FOCUS-MASH).. Therapeutic advances in gastroenterology. 2026. DOI: 10.1177/17562848261462398.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.